PANTOPRAZOLE 20MG 28 GASTRO-RESISTANT TABLETS

Pantoprazole is indicated for use in adults and adolescents 12 years of age and above for:

• Symptomatic gastro-oesophageal reflux disease.

• long-term management and prevention of relapse in reflux oesophagitis.

For long-term management and prevention of relapse in reflux oesophagitis.

• Pantoprazole is indicated for use in adults for: Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment.

Posology

Adults and adolescents 12 years of age and above

Symptomatic gastro-oesophageal reflux disease

The recommended oral dose is one gastro-resistant tablet Pantoprazole 20 mg per day. Symptom relief is generally accomplished within 2-4 weeks. If this is not sufficient, symptom relief will normally be achieved within a further 4 weeks. When symptom relief has been achieved, reoccurring symptoms can be controlled using an on-demand regimen of 20 mg once daily, taking one tablet when required. A switch to continuous therapy may be considered in case satisfactory symptom control cannot be maintained with on-demand treatment.

Long-term management and prevention of relapse in reflux oesophagitis

For long-term management, a maintenance dose of one gastro-resistant tablet Pantoprazole 20 mg per day is recommended, increasing to 40 mg pantoprazole per day if a relapse occurs. Pantoprazole 40 mg is available for this case. After healing of the relapse the dose can be reduced again to 20 mg pantoprazole.

Adults

Prevention of gastroduodenal ulcers induced by non-selective non-steroidal anti-inflammatory drugs (NSAIDs) in patients at risk with a need for continuous NSAID treatment. The recommended oral dose is one gastro-resistant tablet Pantoprazole 20 mg per day.